One of the greatest public health challenges of our century lies in the growth of neurodegenerative disorders. Conditions such as Alzheimer’s disease, Parkinson’s disease, and frontotemporal dementia stand as major contributors to disability and mortality in affluent and under-resourced nations alike. Currently affecting over 55 million individuals, their prevalence is expected increase significantly by 2050—especially in less developed countries, where risk factors are most impactful and mainstream clinical approaches least developed.
You can read the full article here.
